Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats

  • Authors:
    • Xian‑Liang Meng
    • Dong‑Lin Zhang
    • Shi‑Hua Sui
  • View Affiliations / Copyright

    Affiliations: Department of Internal Neurology, Binzhou Central Hospital, Binzhou, Shandong 251700, P.R. China, Department of Encephalopathy, Yangxin Hospital of Traditional Chinese Medicine, Binzhou, Shandong 251800, P.R. China, Department of Internal Neurology, People's Hospital of Rizhao, Rizhao, Shandong 276826, P.R. China
    Copyright: © Meng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1953-1960
    |
    Published online on: July 19, 2019
       https://doi.org/10.3892/etm.2019.7797
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Remote ischemic preconditioning (IPreC) is an effective strategy to defend against cerebral ischemia/reperfusion (IR) injury; however, its mechanisms remain to be elucidated. The aim of the present study was to investigate the effect of IPreC on brain tissue following cerebral ischemia, as well as the underlying mechanisms. Adult male Sprague‑Dawley rats were treated with IPreC for 72 h prior to the induction of transient cerebral ischemia and reperfusion. The results demonstrated that IPreC reduced the area of cerebral infarction in the IR rats by 2,3,5‑triphenyl‑tetrazolium chloride staining. In addition, cell apoptosis was markedly suppressed by IPreC with an increased expression of B‑cell lymphoma 2 (Bcl‑2)/Bcl‑2‑associatd X protein using Terminal deoxynucleotidyl‑transferase‑mediated dUTP nick end labeling assay and western blot analysis. IR induced a decrease in the level of superoxide dismutase, and IPreC significantly suppressed increased levels of malondialdehyde, lactate dehydrogenase and nitric oxide. The expression of CD11b and CD18 was markedly inhibited by IpreC unsing flow cytometry. Furthermore, IPreC markedly decreased the release of pro‑inflammatory factors interleukin (IL)‑6 and IL‑1β, and enhanced the level of anti‑inflammatory factors (IL‑10 and IL‑1 receptor antagonist) by ELISA assay. Finally, IPreC reduced the levels of transforming growth factor‑β‑activated kinase 1, phosphorylated‑P65/P65, and tumor necrosis factor‑α, indicating that the nuclear factor‑κB pathway was involved in IPreC‑mediated protection against cerebral ischemia. Taken together, the results suggested that IPreC decreased ischemic brain injury through alleviating free radical injury and the inflammatory response in cerebral IR rats.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Mestriner RG, Saur L, Bagatini PB, Baptista PP, Vaz SP, Ferreira K, Machado SA, Xavier LL and Netto CA: Astrocyte morphology after ischemic and hemorrhagic experimental stroke has no influence on the different recovery patterns. Behav Brain Res. 278:257–261. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Gomis M and Davalos A: Recanalization and reperfusion therapies of acute ischemic stroke: What have we learned, what are the major research questions, and where are we headed? Front Neurol. 5:2262014. View Article : Google Scholar : PubMed/NCBI

3 

Fjetland L and Roy S: Transcarotid endovascular thrombectomy for acute ischemic stroke. J Vasc Int Radiol. 29:1006–1010. 2018. View Article : Google Scholar

4 

Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, et al: Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 515:431–435. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Hu YQ, Chen W, Yan MH, Lai JJ, Tang N and Wu L: Ischemic preconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PERK pathway. Eur Rev Med Pharmacol Sci. 21:5736–5744. 2017.PubMed/NCBI

6 

Murry CE, Jennings RB and Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI

7 

Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehülsing GJ, Brunecker P, Müller B, et al: Transient ischemic attacks before ischemic stroke: Preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke. 35:616–621. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Lehotsky J, Burda J, Danielisova V, Gottlieb M, Kaplan P and Saniova B: Ischemic tolerance: The mechanisms of neuroprotective strategy. Anat Rec (Hoboken). 292:2002–2012. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Hess DC, Hoda MN and Bhatia K: Remote limb perconditioning [corrected] and postconditioning: Will it translate into a promising treatment for acute stroke? Stroke. 44:1191–1197. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Thompson JW, Dave KR, Young JI and Perez-Pinzon MA: Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics. 10:789–797. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Yunoki M, Kanda T, Suzuki K, Uneda A, Hirashita K and Yoshino K: Ischemic tolerance of the brain and spinal cord: A review. Neurol Med Chir (Tokyo). 57:590–600. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Schoen M, Rotter R, Gierer P, Gradl G, Strauss U, Jonas L, Mittlmeier T and Vollmar B: Ischemic preconditioning prevents skeletal muscle tissue injury, but not nerve lesion upon tourniquet-induced ischemia. J Trauma. 63:788–797. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Jeffries O, Waldron M, Pattison JR and Patterson SD: Enhanced local skeletal muscle oxidative capacity and microvascular blood flow following 7-day ischemic preconditioning in healthy humans. Front Physiol. 9:4632018. View Article : Google Scholar : PubMed/NCBI

14 

Dong S, Cao Y, Li H, Tian J, Yi C and Sang W: Impact of ischemic preconditioning on ischemia-reperfusion injury of the rat sciatic nerve. Int J Clin Exp Med. 8:16245–16251. 2015.PubMed/NCBI

15 

Granger DN and Kvietys PR: Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol. 6:524–551. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Wanchao S, Chen M, Zhiguo S, Futang X and Mengmeng S: Protective effect and mechanism of Lactobacillus on cerebral ischemia reperfusion injury in rats. Braz J Med Biol Res. 51:e71722018. View Article : Google Scholar : PubMed/NCBI

17 

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Matsuda S, Umeda M, Uchida H, Kato H and Araki T: Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats. J Neural Transm (Vienna). 116:395–404. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Angelova PR and Abramov AY: Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett. 592:692–702. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Yao Y, Chen L, Xiao J, Wang C, Jiang W, Zhang R and Hao J: Chrysin protects against focal cerebral ischemia/reperfusion injury in mice through attenuation of oxidative stress and inflammation. Int J Mol Sci. 15:20913–20926. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Singh V, Krishan P and Shri R: Antioxidant-mediated neuroprotection by allium schoenoprasum L. leaf extract against ischemia reperfusion-induced cerebral injury in mice. J Basic Clin Physiol Pharmacol. 29:403–410. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Bohacek I, Cordeau P, Lalancette-Hebert M, Gorup D, Weng YC, Gajovic S and Kriz J: Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J Neuroinflammation. 9:1912012. View Article : Google Scholar : PubMed/NCBI

23 

Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC and Southerland AM: Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag. 10:75–87. 2014.PubMed/NCBI

24 

del Zoppo GJ: Acute anti-inflammatory approaches to ischemic stroke. Ann N Y Acad Sci. 1207:143–148. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Clemens JA, Stephenson DT, Dixon EP, Smalstig EB, Mincy RE, Rash KS and Little SP: Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res Mol Brain Res. 48:187–196. 1997. View Article : Google Scholar : PubMed/NCBI

26 

Subedi L, Venkatesan R and Kim SY: Neuroprotective and anti-inflammatory activities of allyl isothiocyanate through attenuation of JNK/NF-κB/TNF-α signaling. Int J Mol Sci. 18:E14232017. View Article : Google Scholar : PubMed/NCBI

27 

Wang L, Zhang Y, Asakawa T, Li W, Han S, Li Q, Xiao B, Namba H, Lu C and Dong Q: Neuroprotective effect of neuroserpin in oxygen-glucose deprivation- and reoxygenation-treated rat astrocytes in vitro. PLoS One. 10:e01239322015. View Article : Google Scholar : PubMed/NCBI

28 

Giacoppo S, Galuppo M, Iori R, De Nicola GR, Bramanti P and Mazzon E: (RS)-glucoraphanin purified from tuscan black kale and bioactivated with myrosinase enzyme protects against cerebral ischemia/reperfusion injury in rats. Fitoterapia. 99:166–177. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Awooda HA, Lutfi MF, Sharara GM and Saeed AM: Role of N-Nitro-L-Arginine-Methylester as anti-oxidant in transient cerebral ischemia and reperfusion in rats. Exp Transl Stroke Med. 5:12013. View Article : Google Scholar : PubMed/NCBI

30 

Altintas O, Antar V, Baran O, Karatas E, Altintas MO, Kesgin S, Buyukpinarbasili N, Kocyigit A and Asil T: Neuroprotective effects of hemicraniectomy in malign middle cerebral artery infarctions: Experimental study. J Neurosurg Sci. 2015.

31 

Qi D, Liu H, Niu J, Fan X, Wen X, Du Y, Mou J, Pei D, Liu Z, Zong Z, et al: Heat shock protein 72 inhibits c-Jun N-terminal kinase 3 signaling pathway via Akt1 during cerebral ischemia. J Neurol Sci. 317:123–129. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Feng Z, Davis DP, Sasik R, Patel HH, Drummond JC and Patel PM: Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance. Brain Res. 1177:103–123. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Friedlander RM: Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 348:1365–1375. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Dziodzio T, Biebl M and Pratschke J: Impact of brain death on ischemia/reperfusion injury in liver transplantation. Curr Opin Organ Transplant. 19:108–114. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Youle RJ and Strasser A: The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI

36 

Kale J, Osterlund EJ and Andrews DW: BCL-2 family proteins: Changing partners in the dance towards death. Cell Death Differ. 25:65–80. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Zhang J, Yu P, Chen M, Peng Q, Wang Z and Dong N: Remote ischaemic preconditioning and sevoflurane postconditioning synergistically protect rats from myocardial injury induced by ischemia and reperfusion partly via inhibition TLR4/MyD88/NF-κB signaling pathway. Cell Physiol Biochem. 41:22–32. 2017. View Article : Google Scholar : PubMed/NCBI

38 

Jeong JS, Kim D, Kim KY, Ryu S, Han S, Shin BS, Kim GS, Gwak MS and Ko JS: Ischemic preconditioning produces comparable protection against hepatic ischemia/reperfusion injury under isoflurane and sevoflurane anesthesia in rats. Transplant Proc. 49:2188–2193. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Shen S, Zhou J, Meng S, Wu J, Ma J, Zhu C, Deng G and Liu D: The protective effects of ischemic preconditioning on rats with renal ischemia-reperfusion injury and the effects on the expression of Bcl-2 and Bax. Exp Ther Med. 14:4077–4082. 2017.PubMed/NCBI

40 

Ray PD, Huang BW and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24:981–990. 2012. View Article : Google Scholar : PubMed/NCBI

41 

Tothova L and Celec P: Oxidative stress and antioxidants in the diagnosis and therapy of periodontitis. Front Physiol. 8:10552017. View Article : Google Scholar : PubMed/NCBI

42 

Flatow J, Buckley P and Miller BJ: Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 74:400–409. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Yang B, Chen Y, Long YH, Fan X, Liu KX, Wang XB and Zhou J: Intestinal and limb ischemic preconditioning provides a combined protective effect in the late phase, but not in the early phase, against intestinal injury induced by intestinal ischemia-reperfusion in rats. Shock. 49:596–603. 2018. View Article : Google Scholar : PubMed/NCBI

44 

Tuorkey MJ: Kidney remote ischemic preconditioning as a novel strategy to explore the accurate protective mechanisms underlying remote ischemic preconditioning. Interv Med Appl Sci. 9:20–26. 2017.PubMed/NCBI

45 

Oh CS, Kim SH, Lee J and Rhee KY: Impact of remote ischaemic preconditioning on cerebral oxygenation during total knee arthroplasty. Int J Med Sci. 14:115–122. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Stoll G, Jander S and Schroeter M: Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol. 56:149–171. 1998. View Article : Google Scholar : PubMed/NCBI

47 

Lan W, Harmon D, Wang JH, Ghori K, Shorten G and Redmond P: The effect of lidocaine on in vitro neutrophil and endothelial adhesion molecule expression induced by plasma obtained during tourniquet-induced ischaemia and reperfusion. Eur J Anaesthesiol. 21:892–897. 2004. View Article : Google Scholar : PubMed/NCBI

48 

Han JY, Miura S, Akiba Y, Higuchi H, Kato S, Suzuki H, Yokoyama H and Ishii H: Chronic ethanol consumption exacerbates microcirculatory damage in rat mesentery after reperfusion. Am J Physiol Gastrointest Liver Physiol. 280:G939–G948. 2001. View Article : Google Scholar : PubMed/NCBI

49 

Dehnadi A, Benedict Cosimi A, Neal Smith R, Li X, Alonso JL, Means TK and Arnaout MA: Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys. Nat Commun. 8:138992017. View Article : Google Scholar : PubMed/NCBI

50 

Healy DG, Wood AE, O'Neill A, McCarthy JF, Fitzpatrick JM and Watson RW: Can preoperative modelling of individual neutrophil adhesion responses predict renal morbidity? Eur J Cardiothorac Surg. 31:1088–1093. 2007. View Article : Google Scholar : PubMed/NCBI

51 

Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, Peter K and Thiel M: Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: The role of neutrophils. Arch Surg. 140:129–136. 2005. View Article : Google Scholar : PubMed/NCBI

52 

Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J and MacAllister R: Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 103:1624–1630. 2001. View Article : Google Scholar : PubMed/NCBI

53 

Halladin NL, Ekelof S, Alamili M, Bendtzen K, Lykkesfeldt J, Rosenberg J and Gögenur I: Lower limb ischaemia and reperfusion injury in healthy volunteers measured by oxidative and inflammatory biomarkers. Perfusion. 30:64–70. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Choi HS, Hwang JK, Kim JG, Hwang HS, Lee SJ, Chang YK, Kim JI and Moon IS: The optimal duration of ischemic preconditioning for renal ischemia-reperfusion injury in mice. Ann Surg Treat Res. 93:209–216. 2017. View Article : Google Scholar : PubMed/NCBI

55 

Serafin A, Rosello-Catafau J, Prats N, Gelpi E, Rodes J and Peralta C: Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology. 39:688–698. 2004. View Article : Google Scholar : PubMed/NCBI

56 

Shin JA, Park EM, Choi JS, Seo SM, Kang JL, Lee KE and Cho S: Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J Neuroimmunol. 217:14–19. 2009. View Article : Google Scholar : PubMed/NCBI

57 

Kilty I and Jones LH: TAK1 selective inhibition: State of the art and future opportunities. Future Med Chem. 7:23–33. 2015. View Article : Google Scholar : PubMed/NCBI

58 

Wu H, Zhou J, Ou W, Li Y, Liu M and Yang C: TAK1 as the mediator in the protective effect of propofol on renal interstitial fibrosis induced by ischemia/reperfusion injury. Eur J Pharmacol. 811:134–140. 2017. View Article : Google Scholar : PubMed/NCBI

59 

Latanich CA and Toledo-Pereyra LH: Searching for NF-kappaB-based treatments of ischemia reperfusion injury. J Invest Surg. 22:301–315. 2009. View Article : Google Scholar : PubMed/NCBI

60 

Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J and Ogihara T: In vivo transfection of cis element ‘decoy’ against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med. 3:894–899. 1997. View Article : Google Scholar : PubMed/NCBI

61 

Bandarra D, Biddlestone J, Mudie S, Muller HA and Rocha S: Hypoxia activates IKK-NF-kappaB and the immune response in Drosophila melanogaster. Biosci Rep. 34:e001272014. View Article : Google Scholar : PubMed/NCBI

62 

Shin HJ, Won NH and Lee HW: Remote ischemic preconditioning prevents lipopolysaccharide-induced liver injury through inhibition of NF-kappaB activation in mice. J Anesth. 28:898–905. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Meng XL, Zhang DL and Sui SH: Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats. Exp Ther Med 18: 1953-1960, 2019.
APA
Meng, X., Zhang, D., & Sui, S. (2019). Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats. Experimental and Therapeutic Medicine, 18, 1953-1960. https://doi.org/10.3892/etm.2019.7797
MLA
Meng, X., Zhang, D., Sui, S."Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats". Experimental and Therapeutic Medicine 18.3 (2019): 1953-1960.
Chicago
Meng, X., Zhang, D., Sui, S."Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1953-1960. https://doi.org/10.3892/etm.2019.7797
Copy and paste a formatted citation
x
Spandidos Publications style
Meng XL, Zhang DL and Sui SH: Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats. Exp Ther Med 18: 1953-1960, 2019.
APA
Meng, X., Zhang, D., & Sui, S. (2019). Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats. Experimental and Therapeutic Medicine, 18, 1953-1960. https://doi.org/10.3892/etm.2019.7797
MLA
Meng, X., Zhang, D., Sui, S."Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats". Experimental and Therapeutic Medicine 18.3 (2019): 1953-1960.
Chicago
Meng, X., Zhang, D., Sui, S."Acute remote ischemic preconditioning alleviates free radical injury and inflammatory response in cerebral ischemia/reperfusion rats". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1953-1960. https://doi.org/10.3892/etm.2019.7797
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team